Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200545726> ?p ?o ?g. }
- W4200545726 endingPage "e442" @default.
- W4200545726 startingPage "e435" @default.
- W4200545726 abstract "The utility of dose escalation after positive positron emission tomography following 2 cycles of ABVD (PET2) for Hodgkin Lymphoma (HL) remains controversial. We describe the United States real-world practice patterns for PET2 positive patients.Data was collected from 15 sites on PET2 positive HL patients after receiving frontline treatment between January, 2015 and June, 2019. Descriptive analyses between those with therapy change and those continuing initial therapy were assessed.A total of 129 patients were identified; 111 (86%) were treated with ABVD therapy and 18 (14%) with an alternate regimen. At PET2 assessment, 74.4% (96/129) had Deauville score (DS) 4 and 25.6% (33/129) had DS 5. Of the 66 limited stage (LS) patients with PET2 DS score of 4/5, 77.3% (51/66) continued initial therapy and 22.7% (15/66) changed to escalated therapy. The 12-month progression-free survival (PFS) for DS 4/5 LS patients was 67.0% (95% CI; 54.9-81.7) for patients without escalation compared with 51.4% (95% CI; 30.8-85.8) for those who escalated. Of the 63 DS 4/5 patients with advanced stage (AS) disease, 76.2% (48/63) continued initial therapy and 23.8% (15/63) changed to escalated therapy. The 12-month PFS for DS 4/5 AS patients was 38.3% (95% CI: 26.3%-55.7%) for patients without escalation compared with 57.1% (95% CI: 36.3-89.9) for those with escalation.A minority of PET2 positive HL patients undergo therapy escalation and outcomes remain overall suboptimal. Improved prognostics markers and better therapeutics are required to improve outcomes for high-risk PET2 positive HL patients." @default.
- W4200545726 created "2021-12-31" @default.
- W4200545726 creator A5000227859 @default.
- W4200545726 creator A5000703445 @default.
- W4200545726 creator A5001351738 @default.
- W4200545726 creator A5001668616 @default.
- W4200545726 creator A5004343197 @default.
- W4200545726 creator A5005446802 @default.
- W4200545726 creator A5011189067 @default.
- W4200545726 creator A5013717203 @default.
- W4200545726 creator A5017284444 @default.
- W4200545726 creator A5024389256 @default.
- W4200545726 creator A5024844590 @default.
- W4200545726 creator A5031412066 @default.
- W4200545726 creator A5035885270 @default.
- W4200545726 creator A5039574726 @default.
- W4200545726 creator A5040412322 @default.
- W4200545726 creator A5045088400 @default.
- W4200545726 creator A5051862003 @default.
- W4200545726 creator A5052110872 @default.
- W4200545726 creator A5052962596 @default.
- W4200545726 creator A5058757098 @default.
- W4200545726 creator A5060314041 @default.
- W4200545726 creator A5064091455 @default.
- W4200545726 creator A5069849982 @default.
- W4200545726 creator A5082606841 @default.
- W4200545726 creator A5087769984 @default.
- W4200545726 creator A5090212603 @default.
- W4200545726 creator A5090324252 @default.
- W4200545726 date "2022-07-01" @default.
- W4200545726 modified "2023-10-12" @default.
- W4200545726 title "Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience" @default.
- W4200545726 cites W1973535185 @default.
- W4200545726 cites W2010746974 @default.
- W4200545726 cites W2037602782 @default.
- W4200545726 cites W2039888190 @default.
- W4200545726 cites W2051650384 @default.
- W4200545726 cites W2096861751 @default.
- W4200545726 cites W2118169390 @default.
- W4200545726 cites W2124587380 @default.
- W4200545726 cites W2125790189 @default.
- W4200545726 cites W2131900456 @default.
- W4200545726 cites W2137961400 @default.
- W4200545726 cites W2140801657 @default.
- W4200545726 cites W2170821702 @default.
- W4200545726 cites W2209575903 @default.
- W4200545726 cites W2274888609 @default.
- W4200545726 cites W2340968189 @default.
- W4200545726 cites W2469052042 @default.
- W4200545726 cites W2596050027 @default.
- W4200545726 cites W2775803967 @default.
- W4200545726 cites W2784654265 @default.
- W4200545726 cites W2788470141 @default.
- W4200545726 cites W2800320119 @default.
- W4200545726 cites W2891156699 @default.
- W4200545726 cites W2945661283 @default.
- W4200545726 cites W2946457100 @default.
- W4200545726 cites W2963365727 @default.
- W4200545726 cites W3033765098 @default.
- W4200545726 cites W3097472105 @default.
- W4200545726 doi "https://doi.org/10.1016/j.clml.2021.12.012" @default.
- W4200545726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35093285" @default.
- W4200545726 hasPublicationYear "2022" @default.
- W4200545726 type Work @default.
- W4200545726 citedByCount "5" @default.
- W4200545726 countsByYear W42005457262023 @default.
- W4200545726 crossrefType "journal-article" @default.
- W4200545726 hasAuthorship W4200545726A5000227859 @default.
- W4200545726 hasAuthorship W4200545726A5000703445 @default.
- W4200545726 hasAuthorship W4200545726A5001351738 @default.
- W4200545726 hasAuthorship W4200545726A5001668616 @default.
- W4200545726 hasAuthorship W4200545726A5004343197 @default.
- W4200545726 hasAuthorship W4200545726A5005446802 @default.
- W4200545726 hasAuthorship W4200545726A5011189067 @default.
- W4200545726 hasAuthorship W4200545726A5013717203 @default.
- W4200545726 hasAuthorship W4200545726A5017284444 @default.
- W4200545726 hasAuthorship W4200545726A5024389256 @default.
- W4200545726 hasAuthorship W4200545726A5024844590 @default.
- W4200545726 hasAuthorship W4200545726A5031412066 @default.
- W4200545726 hasAuthorship W4200545726A5035885270 @default.
- W4200545726 hasAuthorship W4200545726A5039574726 @default.
- W4200545726 hasAuthorship W4200545726A5040412322 @default.
- W4200545726 hasAuthorship W4200545726A5045088400 @default.
- W4200545726 hasAuthorship W4200545726A5051862003 @default.
- W4200545726 hasAuthorship W4200545726A5052110872 @default.
- W4200545726 hasAuthorship W4200545726A5052962596 @default.
- W4200545726 hasAuthorship W4200545726A5058757098 @default.
- W4200545726 hasAuthorship W4200545726A5060314041 @default.
- W4200545726 hasAuthorship W4200545726A5064091455 @default.
- W4200545726 hasAuthorship W4200545726A5069849982 @default.
- W4200545726 hasAuthorship W4200545726A5082606841 @default.
- W4200545726 hasAuthorship W4200545726A5087769984 @default.
- W4200545726 hasAuthorship W4200545726A5090212603 @default.
- W4200545726 hasAuthorship W4200545726A5090324252 @default.
- W4200545726 hasConcept C126322002 @default.
- W4200545726 hasConcept C146357865 @default.
- W4200545726 hasConcept C151730666 @default.
- W4200545726 hasConcept C2775842073 @default.